Alzheon To Present At Upcoming Asian Healthcare And Scientific Conferences

FRAMINGHAM, Mass.--(BUSINESS WIRE)--Alzheon Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders, today announced that the company will be making presentations at several healthcare and scientific conferences in Asia during October, highlighting biotechnology innovation and drug development for Alzheimer’s disease.

Back to news